뉴스

'False & Fraudulent': NTA Rubbishes Social Media Claims Of NEET-UG Re-Exam Paper Leak

The testing authority reassured aspirants and parents that the integrity of the medical entrance examination remains fully intact

TMC's Firhad Hakim resigns as Kolkata mayor

Kolkata Mayor and Trinamool Congress (TMC) MLA Firhad Hakim has resigned from his post after receiving permission from party supremo Mamata Banerjee, senior TMC leader Kunal Ghosh said on Wednesday, amid deepening turmoil within the opposition party following its electoral defeat in West Bengal.The announcement came as the TMC grappled with its most serious internal crisis since losing power, with a large section of its legislators openly rebelling against the party leadership and seeking a reorganisation of the legislature wing.Also read: TMC crisis deepens as Mamata loyalists attend BJP-led review meetingThe political churn was visible on Wednesday when Hakim, along with TMC MLAs Nayana Bandyopadhyay, Ashok Deb and Kunal Ghosh, attended an administrative review meeting convened by Chief Minister Suvendu Adhikari at Nabanna, a development that added a fresh dimension to the ongoing unrest within the party, PTI reported.The attendance of several leaders considered close to Banerjee at the government meeting came even as the party's legislative wing appeared headed for an unprecedented split.Rebels stake claim to legislature leadershipHours earlier, 58 dissident TMC MLAs formally extended support to expelled legislator Ritabrata Banerjee as the new leader of the legislature party and conveyed their decision to Assembly Speaker Rathindra Bose, according to PTI.Ritabrata Banerjee, accompanied by fellow rebel MLA Sandipan Saha and other dissident legislators, met the Speaker and submitted letters of support purportedly signed by 58 MLAs.The rebel faction also proposed a new leadership structure, naming Ritabrata Banerjee as legislature party leader, Javed Khan, Sandipan Saha and Shiuli Saha as deputy leaders, and Raghunathganj MLA Akhruzzaman as the chief whip.Ritabrata Banerjee, Khan and Saha were also present at the chief minister's administrative review meeting later in the day.The developments followed a gathering of dissident legislators at the Assembly earlier on Wednesday. Significantly, none of the MLAs who attended the rebels' meeting had participated in Mamata Banerjee's dharna in central Kolkata on Tuesday, highlighting the growing divide between the party leadership and the dissident bloc.Also read: TMC rebels back expelled MLA Ritabrata Banerjee as legislature party leader in BengalPolitical signals from administrative meetingsSeveral leaders identified with the Kalighat leadership, including Hakim, Bandyopadhyay, Deb and Ghosh, skipped the Assembly meeting and instead attended the Nabanna review meeting.The latest development comes days after senior TMC MP Kakoli Ghosh Dastidar and six party MLAs attended an administrative review meeting chaired by Adhikari in Kalyani, triggering speculation over shifting political equations within the opposition camp after the assembly election setback.Political observers told PTI that with another set of TMC leaders attending Wednesday's meeting, the line between administrative engagement and political messaging was becoming increasingly blurred in West Bengal's evolving post-election landscape.The BJP government has maintained that such meetings are inclusive administrative exercises. During the previous TMC regime, BJP leaders had often alleged that opposition legislators were excluded from official review meetings.Soon after assuming office, Adhikari announced that opposition MPs and MLAs would be invited to government programmes and district-level administrative review meetings.Also read: TMC dissolves West Bengal units, launches overhaul after poll drubbingParty debates participationReacting to the participation of TMC legislators in such meetings last week, Kunal Ghosh had said the matter was being discussed within the party."We are not in favour of boycotting administrative meetings called by the state government. But when our party workers are being assaulted and rendered homeless in post-poll violence, we need to think twice before attending such meetings. Our party is also discussing whether we should continue participating in these meetings or not," he had said.The ongoing turmoil comes against the backdrop of the TMC's crushing assembly election defeat and growing uncertainty over the party's future leadership structure.

'Economic Fury' on Iran: US seizes Tehran's biggest crypto network amid peace talks

The US has imposed sanctions on Iran's largest cryptocurrency exchange, Nobitex, and its executives, accusing them of aiding the Iranian government and sanctioned entities in bypassing Western restrictions. This move, dubbed 'Economic Fury,' aims to increase economic pressure on Tehran amid ongoing conflicts.

Hubballi: Opportunities galore for those who work with dedication, says judge

A one-day workshop on career guidance was organised by KLE Society’s Gurusiddappa Kotambri Law College in Hubballi on June 2.

'India Better Placed Amid Iran War Than In 2013': Ex-RBI Governor To NDTV

D Subbarao credited the government with taking steps within its control.

Russia launches major attack across Ukraine; several feared trapped after missile-hit building collapses

Russia unleashed a major overnight assault on Ukrainian cities, including Kyiv and Dnipro, hours after President Zelenskyy's warning. Fatalities and injuries were reported in Dnipro, with fears of people trapped in Kyiv's rubble. Meanwhile, a Ukrainian drone strike claimed a civilian life in Russia's Kursk region. Peace efforts remain stalled amidst escalating cross-border attacks.

Hijab ban rollback: Sri Rama Sene distributes saffron shawls to college students in Hubballi

As a mark of protest to Government’s notification allowing hijab in educational institutions, members ofSri Rama Sene distributed saffron shawls to colleges students in Hubballi on Monday.

Pramod Gubbi on investing in a tricky market

Kohli powers RCB to back-to-back IPL crowns

For Gujarat Titans, this was supposed to be Ahmedabad's night.Instead, it became an Ahmeda-bad evening for Shubman Gill's men.Also Read: RCB win IPL for 2 straight years, but this player has created a hat-trick of winsOn a stage draped in blue, in front of a crowd willing the home side towards a second IPL crown, Royal Challengers Bengaluru once again arrived like champions who no longer carry the burden of history. They carried certainty. They carried belief. And, as they have so often over the last two seasons, they carried Virat Kohli.Chasing a modest but tricky 156, RCB were never reckless. They were relentless. Kohli, the grandmaster of the chase and the heartbeat of this franchise, produced yet another knockout innings, crafting a half-century that sucked the anxiety out of the contest and the hope out of Gujarat's defence. It was not his most explosive knock. It did not need to be. It was a classic Kohli pursuit — measured, intelligent and utterly inevitable.The numbers will show another fifty. The final will remember much more than that.For a franchise that spent nearly two decades being cricket's great unfinished story, this felt like the final confirmation that last year's title was not an emotional one-off. This is now a team that understands how to win the biggest games. Two titles in two years is not a breakthrough. It is the beginning of a legacy.Yet Gujarat refused to make it easy.After being restricted to 155, a total that always felt 20 runs short on a placid Ahmedabad surface, the Titans fought with the stubbornness that has defined much of their short IPL history. Rashid Khan, magnificent as ever, dragged the contest deeper than it deserved to go. His spell was a reminder that class survives even when the scoreboard does not cooperate. Every wicket he took briefly reignited belief. Every dot ball lifted the noise levels.Also Read: Rohit, Dhoni, Hardik: When IPL's biggest names couldn't deliver this seasonAnd then there was Rajat Patidar — the quiet captain who has turned Royal Challengers Bengaluru from cricket’s great underachievers into a title machine.A year after leading RCB to their long-awaited maiden IPL crown, Patidar is set to script history again, becoming only the third captain after MS Dhoni and Rohit Sharma to guide a franchise to back-to-back IPL titles. If last season was about breaking an 18-year curse, this one has been about building a champion's mentality.Patidar’s numbers do not scream for attention, but his captaincy has. RCB topped the league stage, steamrolled Gujarat Titans in Qualifier 1, and entered the final carrying the assurance of a side that no longer panics under pressure. The 31-year-old has fostered a dressing-room culture built on clarity and calm, repeatedly insisting throughout the season that every game was “just another match” despite the mounting expectations around a title defence.His fingerprints were all over the campaign. Whether it was trusting Josh Hazlewood in crunch overs, backing Krunal Pandya's experience on spin-friendly surfaces, or ensuring Virat Kohli could play the anchor's role without the burden of forcing the pace, Patidar's tactical calls consistently landed. Most importantly, Patidar has managed something few RCB leaders before him could: he has made the franchise feel bigger than its baggage. For years, RCB were defined by near-misses, heartbreaks and dependence on individual brillianceBut Gujarat's bowlers were left carrying a burden that should never have been theirs alone.The real disappointment lay with the batting.Too many starts disappeared. Too many big names drifted through the final without leaving a mark. At no point did the innings gather the momentum expected from a side stacked with stroke-makers and match-winners. The scoreboard moved, but never surged. The pressure remained, and RCB's attack, led by the discipline of Josh Hazlewood and the control of Krunal Pandya, squeezed relentlessly.By the halfway mark, the script already felt familiar.RCB had been the better side for most of the season. They entered the final as favourites. They played like favourites. And when the moment arrived to finish the job, they handed the chase to the one man who has spent nearly two decades making impossible pursuits look routine.Kohli has worn many labels across his career — superstar, run machine, icon, leader.On nights like these, one title fits best- King Kohli.And with another IPL trophy glistening under the Ahmedabad lights, his kingdom just got bigger

India-Oman trade deal goes live June 1

The Comprehensive Economic Partnership Agreement (CEPA) between India and Oman is set to come into force on June 1, marking a significant milestone in bilateral economic relations. Both nations will formally announce the decision on Monday.This marks the fifth free trade agreement (FTA) implemented under the Modi government since 2014. It follows trade pacts rolled out with Mauritius (April 2021), the UAE (May 2022), Australia (December 2022), and the European Free Trade Association (EFTA—comprising Switzerland, Iceland, Liechtenstein, and Norway in October 2025). India has also signed deals with the UK (July 2025) and New Zealand (April 2026), alongside concluding trade talks with the 27-nation European Union (EU) on January 27 this year.CEPA vs FTAModern trade pacts typically span around 20 chapters. These encompass comprehensive regulations across trade in goods, trade in services, investment, intellectual property rights, customs procedures, and dispute settlement mechanisms.Similar bilateral frameworks are also designated as Comprehensive Economic Cooperation Agreements (CECA), Comprehensive Economic Trade Agreements (CETA), or Economic Cooperation and Trade Agreements (ECTA).Also read: India-Oman CEPA to strengthen energy security, trade resilience and export growthIndia-Oman tradeBilateral trade between the two nations reached USD 11.18 billion during 2025-26, up from USD 10.61 billion in 2024-25. India’s exports stood at USD 4.02 billion, while imports from Oman were valued at USD 7.16 billion.In the services domain, India's exports to Oman expanded from USD 397 million in 2020 to USD 665 million in 2024, driven primarily by telecommunications, computer and information, transport, and travel sectors. Conversely, services imports from Oman grew from USD 101 million to USD 197.7 million over the same period, led by transport, travel, telecom, and other business services.What does India gain? The deal unlocks 100% duty-free market access for Indian exports to Oman, covering 98.08% of Oman’s tariff lines, which represents 99.38% of the trade value (based on the 2022-23 average).Immediate Concessions: All zero-duty access comes into effect from "Day One" of the agreement. Currently, only 15.33% of India’s export value (11.34% of tariff lines) enters Oman duty-free under the Most Favoured Nation (MFN) regime.Price Competitiveness: The pact eliminates the current 5% import duty on Indian goods worth USD 3.64 billion.Growth Drivers: Key sectors poised for immediate advantages include textiles, agricultural products, transport equipment, precision instruments, processed food, and gems & jewellery.New Horizons: The agreement unlocks fresh export windows for Indian minerals, chemicals, base metals, machinery, plastic, rubber, automobiles, clocks, instruments, glass, ceramics, marble, and paper.India-Oman CEPA: Key sectoral gainsOman will grant immediate zero-duty access to crucial Indian industrial segments, including:Iron and steelElectrical and industrial machineryMarine products and copper goodsFurthermore, the removal of the 5% tariff is set to directly bolster the competitiveness of Indian vehicles in the Omani market, while securing binding zero-duty access for key finished medicines and vaccines.India protects sensitive sectorsTo insulate local industries and farming communities, India has placed 2,789 tariff lines on its exclusion list.Excluded Categories: Key domestic sectors shielded from tariff concessions include transport equipment, major chemicals, cereals, fruits, vegetables, spices, coffee, tea, and products of animal origin.Manufacturing Safeguards: High-value manufacturing chains including rubber, leather, textiles, footwear, petroleum oils, and mineral-based products remain protected.Agricultural Shielding: Strategic segments such as dairy products, meat, oilseeds, vegetable oils, sugar, and food-processing residues are entirely kept out of the liberalisation purview.Service sector stands to gainWith Oman’s total global services imports standing at USD 12.52 billion in 2024, India’s current share of 5.31% presents significant room for expansion.Oman has made robust commitments regarding the temporary entry and stay of Indian service professionals. Notably, the Intra-Corporate Transferees (ICT) ceiling has been raised from 20% to 50%, allowing Indian firms to deploy a higher volume of managerial and specialist personnel.Additionally, for the first time in any FTA, Oman has locked in specific commitments for professional service providers, benefitting Indian talent in IT, accounting, engineering, medical, education, construction, and consulting fields.Gains for India's agri sectorIndian agricultural exports such as natural honey, potatoes, cashews, boneless meat, and bakery items will secure immediate duty-free entry into Oman.Oman has agreed to dismantle tariffs—which currently range from 5% to 100%—on an array of items. These include cheese, curd, milk, cream, frozen fish, butter, meat, yoghurt, pastries, cakes, chocolate, sugar confectionery, mineral water, alongside animal and vegetable fats and oils.In return, Indian consumers will benefit from cheaper imports of Omani dates, with India granting zero-duty access for up to 2,000 tonnes of the commodity annually. New Delhi is also extending tariff concessions to Oman’s traditional products: Gum Arabica (utilised in food, pharmaceuticals, and cosmetics) and Frankincense (utilised in the incense and perfume sectors).Oman to benefit from tariff concessionsIndia is extending tariff concessions across 77.79% of its total tariff lines (equivalent to 12,556 lines), which encapsulates 94.81% of India’s total imports from Oman by value.For items that hold significant export value for Oman but remain sensitive for domestic industries in India—such as dates, marbles, and specific petrochemical products—liberalisation will be managed via a controlled Tariff-Rate Quota (TRQ) mechanism.India strengthening presence in Middle EastThe Oman CEPA serves as another pillar in India's deepening trade ties with the Gulf Cooperation Council (GCC), following its May 2022 pact with the UAE. New Delhi is set to commence trade talks with Qatar soon, and has already inked terms of reference (TOR) to initiate broader trade pact negotiations with the entire GCC bloc (comprising Saudi Arabia, UAE, Qatar, Kuwait, Oman, and Bahrain).Despite its size, Oman commands vast geopolitical importance as it borders the Strait of Hormuz, a critical maritime chokepoint heavily relied upon by Asian enterprises for oil trade. The nation serves as a strategic gateway for Indian goods and services into the broader Middle Eastern and African markets.Currently, nearly 7 lakh Indian nationals reside in Oman, sending home approximately USD 2 billion in annual remittances. Over 6,000 Indian establishments operate within Oman, and India has clocked USD 615.54 million in foreign direct investment (FDI) from Oman between April 2000 and September 2025. Notably, this CEPA is the first bilateral trade pact Oman has signed with any nation since its agreement with the United States in 2006, cementing its position as India’s third-largest export market within the GCC.

Zoho founder quotes Oracle’s Larry Ellison on AI’s future

Zoho founder Sridhar Vembu echoed Larry Ellison's view that AI is rapidly commoditizing, with value shifting to applications built around it. Ellison argued that similar public data training makes AI models less of a differentiator, emphasizing exclusive datasets as the future competitive edge. Vembu also recently described the AI boom as a significant investment bubble.

Molecule glue drugs shake up cancer care

One of the biggest advances in pancreatic cancer in decades came out of a crazy idea born in a Harvard University lab.Chemical biologist Gregory Verdine believed you could fight disease-causing proteins hidden inside cells by chemically gluing them to something else in the body and smothering them."Everybody told us this is crazy, that it would never work," he recalls.Revolution Medicines, which bought one of Verdine's companies in 2018, recently announced that one of its drugs doubled the typical survival time for patients with aggressive forms of the disease, from 6.7 months to 13.2 months. The full results from the company's final-stage trial are expected to be the star of the show at the annual confab of cancer doctors in Chicago this weekend.Spurred by the success of RevMed, numerous companies are now racing to develop similar drugs, dubbed "molecular glues", which can be used to treat a variety of ailments. And investors and pharmaceutical companies with deep pockets are chasing after them, creating one of the hottest corners of dealmaking in the industry.Also read | India's out-of-pocket healthcare spending drops significantly, govt data showsIt's not unusual for exciting new drugs to spark surges in stock prices and dealmaking frenzy. But molecular glue is a particularly complicated science, and the startups pursuing technologies similar to RevMed are mostly in early stages of testing. Their medicines won't be ready for years, if ever.That hasn't stopped big drugmakers such as Novartis, Roche Holding and Eli Lilly from inking research pacts with glue developers that could pay out billions of dollars in milestones.The boom has been especially lucrative for Monte Rosa Therapeutics. Over the past three years, the Boston-based biotech firm has signed three agreements that could be worth over $10 billion to develop molecular glue drugs with both Novartis and Roche.The company, which trades under the stock ticker GLUE, has seen its shares surge nearly 400% over the past year. It's preparing to start mid-stage trials for multiple drugs by the end of this year."The run-up in the share price is justified based on what we've seen so far," says Robert Driscoll, an analyst at Wedbush. Gains are "due to the success of their drugs rather than kind of exuberance around the glue technology as a whole", he says.Science of GlueMolecular glues work in a fundamentally different way from other oral medicines. Most pills - like Prozac for depression or Lipitor for cholesterol - are tiny chemicals that squeeze into a pocket inside a much larger protein to gum up its functioning. But many proteins have few obvious pockets, including key cancer-causing proteins.In fact, about 80% of all proteins in the body are what scientists refer to as "undruggable", meaning they can't be targeted with traditional drug technologies.RevMed's daraxonrasib cleverly circumvents this problem by acting as a molecular stickum. Once inside the body it binds to a healthy protein on one side and then draws in the bad protein to stick to the other side. The healthy protein helps block the bad protein and turn off its signalling.Competitors Line UpMultiple companies are chasing RevMed's lead in pancreatic cancer despite the long odds. San Diego-based Erasca is in early stages of testing a drug it says is more potent than daraxonrasib. Japanese drugmaker Astellas Pharma has begun final-stage trials of a degrader that may help a subset of pancreatic and lung cancer patients.Molecular glues are also being developed as alternatives to injectable drugs used to treat autoimmune and skin disorders. Shares of Kymera Therapeutics have soared more than 180% in the past year thanks to promising early trial results. The company is developing a once-daily pill it hopes will one day compete with Sanofi and Regeneron Pharmaceuticals' Dupixent, one of the world's bestselling drugs."The technology allows you to go after things that would have been almost impossible" to do previously with pills, says Nello Mainolfi, Kymera's founder and CEO.With few effective options for pancreatic cancer, analysts expect RevMed's daraxonrasib to become an enormous bestseller for the company.Prospects for daraxonrasib and speculation about a potential takeout deal have inflated RevMed's market cap to nearly $33 billion. That's a lofty figure for a drugmaker with no approved medicines.The company is preparing to file for US approval soon, and the FDA has promised to give the drug an ultrafast review. It's projected to reach $7 billion in sales a year by 2032, according to the average of estimates compiled by Bloomberg.

Meet Parveen Shaikh & Barkha Subba: Indian conservationists who won ‘Green Oscars’

BJP MLA Mahesh Tenginakai insulted migrant workers in Hubballi assuming they are infiltrators, says Congress leader Rajat Ullagaddimath

Congress leader criticises police officers, who were present, accusing them of failing to follow the rule of law

Govt. committed to reviving Nandi awards, says Cinematography Minister Durgesh

He calls upon producers and film personalities to invest in studios, dubbing theatres and recording facilities in the State; Bharat Bhushan takes over as Andhra Pradesh State Film, Television and Theatre Development Corporation

Hubballi Dharwad Central MLA tells officials to facilitate export of mangoes grown in region

Emphasising the need for facilitating export of the mangoes grown by the farmers of the region, Hubballi Dharwad Central MLA Mahesh Tenginakai has said the officials should provide requisite information and handhold the farmers initially